Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05772702 · ClinicalTrials.gov registry record · NA
Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Depression
A NA study, sponsored by Electromedical Products International.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT05772702 is a NA study that has completed, run by Electromedical Products International. The registered enrollment target is 26 participants.
The verdict
NCT05772702, a NA study, has completed, sponsored by Electromedical Products International.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this research study is to study closed-loop transcranial alternating current stimulation (tACS) to determine its effects on symptoms of depression in people with major depressive disorder.
Interventions
- DEVICE Closed-loop tACS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2023-02-13 |
| Est. Completion | 2024-08-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05772702
The ClinicalTrials.gov registry entry for NCT05772702 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Electromedical Products International, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Closed-loop tACS is the first listed.
NCT05772702 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05772702 about?
NCT05772702 is a clinical study titled "Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Depression". The purpose of this research study is to study closed-loop transcranial alternating current stimulation (tACS) to determine its effects on symptoms of depression in people with major depressive disorder.
What is the current status of trial NCT05772702?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2023-02-13. Estimated completion is 2024-08-19.
What interventions are being tested in trial NCT05772702?
The interventions under investigation include: Closed-loop tACS (DEVICE).
Who is sponsoring clinical trial NCT05772702?
This trial is sponsored by Electromedical Products International, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.